Back
SCYNEXIS 10K Form
Buy
71
SCYX
SCYNEXIS
Last Price:
1.78
Seasonality Move:
-11.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-13 | 10Q | SCYX/SCYNEXIS Quarterly |
| 2023-08-14 | 10Q | SCYX/SCYNEXIS Quarterly |
| 2023-05-10 | 10Q | SCYX/SCYNEXIS Quarterly |
| 2022-11-09 | 10Q | SCYX/SCYNEXIS Quarterly |
| 2022-08-15 | 10Q | SCYX/SCYNEXIS Quarterly |
| 2022-05-12 | 10Q | SCYX/SCYNEXIS Quarterly |
Receive SCYX News And Ratings
See the #1 stock for the next 7 days that we like better than SCYX
SCYX Financial Statistics
Sales & Book Value
| Annual Sales: | $140.14M |
|---|---|
| Cash Flow: | $-7.74M |
| Price / Cash Flow: | 1.39 |
| Annual Sales: | $1.96 |
| Price / Book: | 0.9 |
Profitability
| EPS (TTM): | 1.30000 |
|---|---|
| Net Income (TTM): | $67.04M |
| Gross Margin: | $124.52M |
| Return on Equity: | 144.89% |
| Return on Assets: | 56.82% |
SCYNEXIS Earnings Forecast
Key SCYNEXIS Financial Ratios
- The Gross Profit Margin over the past 9 years for SCYX is 88.85%.
- The Selling, General & Administrative Expenses for SCYX have been equal to 14.93% of Gross Profit Margin.
- The Research & Development expenses have been 22.07% of Revenue.
- The Interest Expense is 4.67% of Operating Income.
- The Net Earning history of SCYX is 47.84% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 8 years.
SCYNEXIS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SCYX |
| CUSIP: | 811292 |
| Website: | scynexis.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 6.26 |
| Quick Ratio: | 5.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 1.24 |
|---|---|
| Forward P/E Ratio: | 78.64 |